KPRX
Kiora Pharmaceuticals Inc
NASDAQ: KPRX · HEALTHCARE · BIOTECHNOLOGY
$2.44
+3.83% today
Updated 2026-05-01
Market cap
$10.53M
P/E ratio
—
P/S ratio
0.14x
EPS (TTM)
$-2.64
Dividend yield
—
52W range
$2 – $4
Volume
0.6M
Kiora Pharmaceuticals Inc (KPRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.34M | $692194.00 | $1.41M | $9.51M | $9.73M | $14.31M | $14.28M | $10.11M | $15.30M | $20.13M | $18.68M | $13.71M | $36.48M |
| Cash & equivalents | $1.97M | $501172.00 | $167000.00 | $8.39M | $3.64M | $7.81M | $8.00M | $3.78M | $1.19M | $7.85M | $5.96M | $2.45M | $3.79M |
| Current assets | $2.05M | $558647.00 | $218780.00 | $9.45M | $4.15M | $8.46M | $8.48M | $4.32M | $1.73M | $8.99M | $7.68M | $4.74M | $29.71M |
| Total liabilities | $37.16M | $38.98M | $41.43M | $3.42M | $10.06M | $16.23M | $5.34M | $3.49M | $5.57M | $5.55M | $7.27M | $7.60M | $10.72M |
| Current liabilities | $747084.00 | $2.57M | $5.02M | $3.42M | $7.31M | $14.83M | $3.86M | $1.41M | $1.98M | $1.61M | $3.27M | $1.63M | $6.01M |
| Long-term debt | — | — | — | — | — | — | — | — | $278190.00 | — | — | — | — |
| Shareholder equity | $-41.16M | $-44.84M | $-46.81M | $6.09M | $-329421.00 | $-1.93M | $8.94M | $6.62M | $9.73M | $14.58M | $11.41M | $6.11M | $25.76M |
| Retained earnings | $-51.21M | $-55.09M | $-56.86M | $-65.26M | $-78.60M | $-91.82M | $-93.15M | $-100.25M | $-107.11M | $-120.88M | $-134.46M | $-146.98M | $-143.38M |
| Accounts receivable | $38720.00 | $35124.00 | $25336.00 | $932586.00 | $53833.00 | $23685.00 | $18436.00 | $4857.00 | $90975.00 | $529560.00 | $1.37M | $2.05M | $601197.00 |
| Inventory | — | — | — | — | — | — | — | — | — | — | — | $1.00 | — |
| Goodwill | — | — | — | — | $5.44M | $5.44M | $1.53M | $1.53M | $3.63M | $0.00 | — | — | — |